Autoimmune Disease Diagnostics Market Size, Share, Growth and Forecast (2026 - 2036)

Autoimmune Disease Diagnostics Market is segmented by Product (Immunoassay Based Diagnostics, Molecular Diagnostics, Autoantibody Tests, Point of Care Diagnostics, Multiplex Diagnostic Panels, Specialized Diagnostic Kits), Technology (Immunodiagnostics Technology, Fluorescence Based Technology, Molecular Diagnostics Technology, Biosensor Technology, Automated Laboratory Systems), Disease Type (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Celiac Disease, Type 1 Diabetes, Thyroid Autoimmune Disorders, Multiple Sclerosis, Inflammatory Bowel Disease), and Region, with forecasts covering the period from 2026 to 2036.

Free Sample
Download PDF

Autoimmune Disease Diagnostics Market Analysis and Forecast by Fact.MR

  • The global autoimmune disease diagnostics market is estimated at US$ 6.1 billion in 2025 and has been forecast to expand at a CAGR of 6.3% to reach US$ 11.9 billion by 2036.
  • Autoimmune disease diagnostics encompass immunoassay, fluorescence, and molecular diagnostic products used to detect autoantibodies and inflammatory biomarkers associated with conditions including rheumatoid arthritis, systemic lupus erythematosus, celiac disease, and thyroid autoimmunity.
  • Immunoassay-based diagnostics account for the largest product share, with rheumatoid arthritis representing the leading disease category by testing volume.
  • Hospitals and diagnostic laboratories form the primary testing settings.

Autoimmune Disease Diagnostics Market Market Value Analysis

Summary of Autoimmune Disease Diagnostics Market

  • Market Snapshot
    • In 2025, the global Autoimmune Disease Diagnostics Market was valued at approximately USD 6.1 billion.
    • The market is estimated to reach USD 6.5 billion in 2026 and is projected to attain USD 11.9 billion by 2036.
    • The autoimmune disease diagnostics market is likely to expand at a CAGR of 6.3% during the forecast period.
    • The market is anticipated to create an absolute dollar opportunity of USD 5.4 billion between 2026 and 2036.
    • Immunoassay Based Diagnostics accounts for 38.9% of product share in 2026.
    • USA (6.9%) and Germany (6.7%) are the key growth markets during the forecast period.
  • Demand and Growth Drivers
    • Autoimmune disease prevalence growth, affecting an estimated 5 to 8 percent of the global population, is expanding the patient pool requiring diagnostic serological testing.
    • Earlier diagnosis initiatives driven by rheumatology and immunology society guidelines are increasing testing volumes at earlier stages of disease presentation.
    • Automated immunoassay platform adoption in hospital and reference laboratories is improving testing throughput and reducing per-test cost for autoantibody panels.
    • Multiplex autoantibody profiling panels that test for multiple markers from a single sample are replacing sequential single-marker testing, improving diagnostic efficiency.
    • Celiac disease screening awareness expansion, with population-level prevalence of approximately 1 percent in Western populations, is generating incremental serological testing demand.
  • Product and Segment View
    • Immunoassay Based Diagnostics accounts for 38.9% of the product segment in 2026, supported by strong installed base and continued procurement across primary end use channels.
    • Immunodiagnostics Technology accounts for 41.5% of the technology segment in 2026, reflecting concentrated demand across established application areas.
    • Rheumatoid Arthritis accounts for 34.2% of the disease type segment in 2026, with adoption rising across both developed and emerging markets.
    • Key segmentation includes:
      • Product: Immunoassay Based Diagnostics, Molecular Diagnostics, Autoantibody Tests
      • Technology: Immunodiagnostics Technology, Fluorescence Based Technology, Molecular Diagnostics Technology
      • Disease Type: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Celiac Disease
      • Sample Type: Blood Samples, Saliva Samples, Urine Samples
    • These systems enable:
      • Targeted procurement and specification alignment across buyer segments
      • Performance benchmarking across product and application categories
      • Regional demand mapping across 30 plus countries
  • Geography and Competitive Outlook
    • North America accounts for a large share of global demand, supported by established procurement channels and a mature buyer base.
    • Europe shows stable demand, with Germany (6.7%) contributing through regulatory compliance and institutional procurement for autoimmune disease diagnostics products.
    • Asia Pacific demand is led by Japan (6.3%) and China (6.1%).
    • USA (6.9%) and Germany (6.7%) are the fastest growing country markets during the forecast period.
    • Leading companies include F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, Abbott, Beckman Coulter, Inc., Danaher Corporation.
  • Analyst Opinion
    • Shambhu Nath Jha, Principal Consultant at Fact.MR, says 'The autoimmune disease diagnostics market is growing steadily as disease awareness improves, testing technology advances, and clinical guidelines incorporate earlier screening recommendations. Roche leads through its broad Elecsys immunoassay autoimmune menu, while Siemens, Abbott, and EUROIMMUN compete across complementary platform and specialty diagnostic segments. The shift toward multiplex profiling and AI-assisted interpretation will define the next competitive phase, rewarding companies that combine broad autoantibody menus with automated workflow solutions.'

Key Growth Drivers, Constraints, and Opportunities

Autoimmune Disease Diagnostics Market Opportunity Matrix Growth Vs Value

Key Factors Driving Growth

  • Autoimmune disease prevalence growth, affecting an estimated 5 to 8 percent of the global population, is expanding the patient pool requiring diagnostic serological testing.
  • Earlier diagnosis initiatives driven by rheumatology and immunology society guidelines are increasing testing volumes at earlier stages of disease presentation.
  • Automated immunoassay platform adoption in hospital and reference laboratories is improving testing throughput and reducing per-test cost for autoantibody panels.

Key Market Constraints

  • Autoantibody test specificity limitations, where positive results can occur in healthy individuals, create clinical interpretation challenges and unnecessary follow-up testing.
  • Laboratory standardization gaps across autoantibody assay platforms produce inter-laboratory variability that complicates result comparison and guideline development.
  • Low disease awareness among primary care physicians for less common autoimmune conditions delays referral for diagnostic testing and specialist evaluation.

Key Opportunity Areas

  • Multiplex autoantibody panels that simultaneously screen for rheumatoid factor, anti-CCP, ANA, and organ-specific autoantibodies are creating comprehensive screening tools for primary care ordering.
  • Artificial intelligence-assisted pattern recognition for indirect immunofluorescence ANA testing is reducing manual interpretation workload and improving inter-observer agreement.
  • Point-of-care autoimmune screening devices for rheumatoid factor and anti-CCP in primary care settings could shift early disease detection from specialist referral to first-contact assessment.

Segment-wise Analysis of the Autoimmune Disease Diagnostics Market

  • Immunoassay Based Diagnostics holds 38.9% of the product segment in 2026, supported by established demand channels and continued procurement across primary end use applications.
  • Immunodiagnostics Technology holds 41.5% of the technology segment in 2026, supported by established demand channels and continued procurement across primary end use applications.
  • Rheumatoid Arthritis holds 34.2% of the disease type segment in 2026, supported by established demand channels and continued procurement across primary end use applications.

The autoimmune disease diagnostics market is segmented by product, technology, disease type, sample type, and region.

By product, the market covers Immunoassay Based Diagnostics, Molecular Diagnostics, Autoantibody Tests.

By technology, coverage includes Immunodiagnostics Technology, Fluorescence Based Technology, Molecular Diagnostics Technology.

Which Product Segment Dominates the Autoimmune Disease Diagnostics Market?

Autoimmune Disease Diagnostics Market Analysis By Product

Immunoassay Based Diagnostics is expected to account for 38.9% of the product segment in 2026. Within this category, Enzyme Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Radioimmunoassay represent the primary sub-segments generating procurement activity. The depth of the immunoassay based diagnostics installed base across product applications sustains replacement demand and limits share erosion from newer alternatives in the autoimmune disease diagnostics market.

Molecular Diagnostics is the second largest category in the product segment, with demand concentrated in Polymerase Chain Reaction Assays and Real Time PCR Kits. Growth in molecular diagnostics reflects shifting buyer requirements within the autoimmune disease diagnostics market toward this category.

Which Technology Segment Dominates the Autoimmune Disease Diagnostics Market?

Autoimmune Disease Diagnostics Market Analysis By Technology

Immunodiagnostics Technology is expected to account for 41.5% of the technology segment in 2026. Within this category, Enzyme Immunoassay Technology, Chemiluminescent Detection Systems represent the primary sub-segments generating procurement activity. The depth of the immunodiagnostics technology installed base across technology applications sustains replacement demand and limits share erosion from newer alternatives in the autoimmune disease diagnostics market.

Fluorescence Based Technology is the second largest category in the technology segment, with demand concentrated in Flow Cytometry Based Assays and Multiplex Fluorescent Detection. Growth in fluorescence based technology reflects shifting buyer requirements within the autoimmune disease diagnostics market toward this category.

Which Disease Type Segment Dominates the Autoimmune Disease Diagnostics Market?

Autoimmune Disease Diagnostics Market Analysis By Disease Type

Rheumatoid Arthritis is expected to account for 34.2% of the disease type segment in 2026. Within this category, Seropositive Rheumatoid Arthritis, Seronegative Rheumatoid Arthritis represent the primary sub-segments generating procurement activity. The depth of the rheumatoid arthritis installed base across disease type applications sustains replacement demand and limits share erosion from newer alternatives in the autoimmune disease diagnostics market.

Systemic Lupus Erythematosus is the second largest category in the disease type segment, with demand concentrated in Cutaneous Lupus and Systemic Lupus Variants. Growth in systemic lupus erythematosus reflects shifting buyer requirements within the autoimmune disease diagnostics market toward this category.

Which Product Trend is Shaping the Next Phase of Growth in the Autoimmune Disease Diagnostics Market?

AI-assisted indirect immunofluorescence (IIF) pattern recognition is the technology advancement reshaping autoimmune disease diagnostic workflow. ANA testing by IIF is the gold standard for systemic autoimmune disease screening, but manual microscopic pattern interpretation is time-consuming, subjective, and requires experienced laboratory staff. AI-powered digital imaging systems can classify ANA patterns with accuracy comparable to expert readers, enabling higher throughput and more consistent results.

EUROIMMUN EUROPattern, Inova Diagnostics QUANTA Link, and other AI-assisted IIF systems are gaining adoption in high-volume reference and hospital laboratories. For the autoimmune diagnostics market, AI integration addresses a structural bottleneck that has limited IIF testing capacity and created variability between laboratories. Broader adoption of automated IIF interpretation could expand ANA testing volumes by making it feasible in laboratories that previously lacked the expertise for manual pattern reading.

Regional Outlook Across Key Markets

Top Country Growth Comparison Autoimmune Disease Diagnostics Market Cagr (2026 2036)

  • USA is growing at 6.9%, supported by high testing volumes, specialty laboratory infrastructure, and rheumatology guideline adoption.
  • Germany is growing at 6.7%, supported by EUROIMMUN domestic strength, DGRh guidelines, and statutory health insurance coverage.
  • UK is growing at 6.5%, supported by NHS laboratory infrastructure, NICE diagnostic pathways, and BSR diagnostic standards.
  • Japan is growing at 6.3%, supported by rheumatoid arthritis prevalence, JCR guideline adoption, and NHI testing coverage.

CAGR Table

Country CAGR (%)
USA 6.9%
Germany 6.7%
UK 6.5%
Japan 6.3%
China 6.1%
India 5.8%
France 5.6%

Source: Fact MR (FMR) analysis, based on proprietary forecasting model and primary research.

Autoimmune Disease Diagnostics Market Cagr Analysis By Country

Market Outlook for Autoimmune Disease Diagnostics in USA

Autoimmune Disease Diagnostics Market Country Value Analysis

The USA Autoimmune Disease Diagnostics market is projected to grow at a CAGR of 6.9% through 2036. The U.S. is the largest autoimmune disease diagnostics market, driven by high testing volumes, specialty laboratory infrastructure, and rheumatology guideline adoption.

  • ACR and ANA testing guidelines define serological workup algorithms for rheumatoid arthritis and systemic lupus evaluation.
  • Quest Diagnostics, Labcorp, and Exagen Diagnostics reference laboratories process the majority of autoimmune test volumes.
  • Automated IIF and multiplex platforms are gaining adoption in high-volume reference laboratories seeking throughput improvement.

Autoimmune Disease Diagnostics Demand Trends in Germany

The Germany Autoimmune Disease Diagnostics market is projected to grow at a CAGR of 6.7% through 2036. Germany is a leading European autoimmune diagnostics market, supported by clinical laboratory infrastructure and EUROIMMUN domestic strength.

  • EUROIMMUN, headquartered in Germany, is the leading specialized autoimmune diagnostics company globally.
  • German rheumatology society (DGRh) diagnostic guidelines inform autoantibody testing algorithms for rheumatic disease evaluation.
  • Statutory health insurance coverage for indicated autoimmune testing supports patient access through physician ordering.

UK Autoimmune Disease Diagnostics Market Growth Outlook

The UK Autoimmune Disease Diagnostics market is projected to grow at a CAGR of 6.5% through 2036. NHS laboratory infrastructure and NICE diagnostic pathways support autoimmune testing demand in the United Kingdom.

  • NICE clinical guidelines for rheumatoid arthritis and lupus define testing recommendations that drive NHS laboratory autoantibody volumes.
  • NHS centralized laboratory procurement frameworks create reagent supply contracts that favor established immunoassay platform suppliers.
  • BSR (British Society for Rheumatology) standards inform autoimmune diagnostic test ordering and interpretation practices.

Japan Autoimmune Disease Diagnostics Market Demand Analysis

Autoimmune Disease Diagnostics Market Japan Market Share Analysis By Product

The Japan Autoimmune Disease Diagnostics market is projected to grow at a CAGR of 6.3% through 2036. Established rheumatology practice and autoimmune disease prevalence sustain diagnostics demand in Japan.

  • Rheumatoid arthritis prevalence of approximately 0.5 to 1% of the adult population generates the largest single-disease testing volume.
  • Japanese College of Rheumatology guidelines inform autoantibody testing panels for early RA and systemic autoimmune disease diagnosis.
  • NHI coverage for indicated autoimmune serological testing supports physician ordering through established laboratory channels.

Autoimmune Disease Diagnostics Market Growth Assessment in China

The China Autoimmune Disease Diagnostics market is projected to grow at a CAGR of 6.1% through 2036. Hospital laboratory expansion and growing autoimmune disease awareness support diagnostics growth in China.

  • Autoimmune disease awareness improvement among Chinese physicians is increasing testing referral rates from primary care.
  • Tier-2 city hospital laboratory investment in automated immunoassay platforms is expanding autoimmune testing access beyond tier-1 centers.
  • Domestic diagnostic companies are developing cost-competitive autoantibody assay platforms for the Chinese institutional market.

Autoimmune Disease Diagnostics Market Opportunity Outlook in India

The India Autoimmune Disease Diagnostics market is projected to grow at a CAGR of 5.8% through 2036. Growing rheumatology capacity and diagnostic laboratory chain expansion support autoimmune testing in India.

  • Diagnostic laboratory chains including Thyrocare, SRL, and Metropolis are expanding autoimmune test menus across Indian cities.
  • Growing rheumatology specialist numbers in urban centers are improving referral rates for autoantibody testing.
  • Cost-effective immunoassay platforms are enabling autoimmune testing access at price points appropriate for the Indian market.

Demand Landscape for Autoimmune Disease Diagnostics in France

The France Autoimmune Disease Diagnostics market is projected to grow at a CAGR of 5.6% through 2036. Established immunology practice and hospital laboratory infrastructure sustain autoimmune diagnostics demand in France.

  • French rheumatology and immunology society guidelines define autoantibody testing algorithms for disease evaluation.
  • Hospital and reference laboratory autoimmune testing capability is well established across French university hospital networks.
  • HAS technology evaluations assess new autoimmune diagnostic tests for clinical utility and reimbursement consideration.

Competitive Benchmarking and Company Positioning

Autoimmune Disease Diagnostics Market Analysis By Company

Autoimmune Disease Diagnostics Market Analysis By Company

  • F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, Abbott, Beckman Coulter, Inc. hold established positions in the global autoimmune disease diagnostics market through broad product portfolios, geographic reach, and growing capabilities in higher specification categories.
  • Danaher Corporation, Quest Diagnostics, EUROIMMUN Medizinische Labordiagnostika AG, Nova Diagnostics Pte Ltd participate across specific price tiers, end use segments, and regional channels, with competition shaped by product quality, service support, and distribution access.
  • Autoantibody test menu breadth, immunoassay platform automation level, and AI-assisted interpretation capability are the primary competitive differentiators.

F. Hoffmann-La Roche Ltd leads the autoimmune disease diagnostics market through its Elecsys immunoassay platform and broad autoantibody test menu. Siemens Healthcare competes through its Atellica and IMMULITE platforms. Abbott participates through its ARCHITECT and Alinity immunoassay systems. Beckman Coulter Inc. (Danaher) serves through its DxI immunoassay platform. EUROIMMUN (PerkinElmer) specializes in autoantibody testing with IIF, ELISA, and line immunoassay formats.

Competition is segmented between large immunoassay platform companies offering autoimmune tests as part of consolidated laboratory menus (Roche, Siemens, Abbott, Beckman Coulter) and specialized autoimmune diagnostics companies offering dedicated testing solutions (EUROIMMUN, Inova Diagnostics). Platform consolidation in large laboratories favors vendors with the broadest automated menus, while specialty autoimmune laboratories prefer dedicated systems with deeper autoantibody coverage and specialized interpretation support.

Key Companies in the Autoimmune Disease Diagnostics Market

  • F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, Abbott, Beckman Coulter, Inc. are among the leading players in the autoimmune disease diagnostics market globally, supported by strong brand visibility and broad product portfolios.
  • Danaher Corporation, Quest Diagnostics, EUROIMMUN Medizinische Labordiagnostika AG, Nova Diagnostics Pte Ltd hold established positions across specific categories, supported by durable products and regional distribution.

Recent Industry Developments

  • F. Hoffmann-La Roche Ltd - AI Pattern Recognition (January 2026)
    • F. Hoffmann-La Roche Ltd launched an AI-assisted ANA pattern classification system for indirect immunofluorescence testing, reducing manual slide reading time by 70% while maintaining expert-level classification accuracy.
  • Siemens Healthcare Private Limited - Multiplex RA Panel (2025)
    • Siemens Healthcare Private Limited introduced a multiplex rheumatoid arthritis diagnostic panel combining anti-CCP, rheumatoid factor, and anti-carbamylated protein antibody detection on a single automated immunoassay platform.
  • Abbott - Digital IIF Platform (2025)
    • Abbott released a digital slide scanning system for immunofluorescence autoantibody testing that enables remote expert consultation and archived digital result review.
  • Beckman Coulter, Inc. - Lupus Biomarker Test (March 2026)
    • Beckman Coulter, Inc. announced FDA clearance for a novel lupus activity biomarker test measuring interferon-inducible gene expression, providing objective disease activity monitoring for SLE patients.

Leading Companies Shaping the Autoimmune Disease Diagnostics Market

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare Private Limited
  • Abbott
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • Quest Diagnostics
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Nova Diagnostics Pte Ltd
  • Biomérieux
  • Hemagen Diagnostics, Inc.

Sources and Research References

  • F. Hoffmann-La Roche Ltd. Product portfolio and corporate announcements.
  • Siemens Healthcare Private Limited. Product portfolio and corporate announcements.
  • Abbott. Product portfolio and corporate announcements.
  • Industry association statistics, regulatory publications, trade databases, and company product catalogs.
  • Primary interviews with manufacturers, distributors, buyers, and institutional users.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

Key Questions This Report Addresses

  • What is the current and future size of the Autoimmune Disease Diagnostics Market?
  • How fast is the Autoimmune Disease Diagnostics Market expected to grow between 2026 and 2036?
  • Which product is likely to lead the market by 2026?
  • Which technology segment is expected to account for the highest demand by 2026?
  • What factors are driving demand in this market globally?
  • How is technology adoption influencing the market structure?
  • Which countries are projected to show the fastest growth through 2036?
  • What is driving market expansion in USA and Germany?
  • Who are the key companies active in the Autoimmune Disease Diagnostics Market?
  • How does Fact.MR estimate and validate the market forecast?

Autoimmune Disease Diagnostics Market Definition

The autoimmune disease diagnostics market covers products, technologies, and services associated with product, technology, disease type categories. The scope includes global and regional market size and forecasts for 2026 to 2036 across product, technology, disease type, sample type, and region.

Autoimmune Disease Diagnostics Market Inclusions

  • The scope covers global and regional market size and forecasts for 2026 to 2036 across product, technology, disease type, sample type, and region.
  • It includes regional demand analysis across major geographies, based on factors such as technology adoption, regulatory requirements, institutional spending, and commercial demand patterns.
  • The report includes pricing and cost analysis across entry-level, mid-range, and premium categories, including hardware, software, and service components where applicable.
  • It covers technology trends, market drivers and constraints, and the competitive landscape, including product portfolios, pricing strategy, geographic reach, and distribution expansion of leading players.

Autoimmune Disease Diagnostics Market Exclusions

  • The scope excludes adjacent categories, general-purpose alternatives, and products not specifically classified under the autoimmune disease diagnostics market taxonomy.
  • It excludes custom-built in-house solutions, informal unbranded products with low market visibility, and rental or leasing services without direct product sales.
  • The report excludes military or defense-grade variants, industrial systems outside the defined scope, and non-commercial applications without market transaction data.
  • It also excludes software-only platforms sold independently from hardware, unless they are part of the defined product or service taxonomy.

Autoimmune Disease Diagnostics Market Research Methodology

  • The methodology combines secondary research, primary interviews, and forecast modelling.
  • It draws on 120 plus secondary sources and benchmarks 65 plus company product portfolios.
  • Market sizing covers 30 plus countries through a demand-side model, supported by top-down validation.
  • Key inputs include end use adoption rates, technology penetration, pricing benchmarks, and regional procurement patterns.
  • The model cross-checks demand with shipments, pricing trends, channel mix, and product launches.
  • Primary validation includes 25 plus interviews across manufacturers, distributors, buyers, and institutional users.
  • Final estimates go through trade-flow checks, sales-pattern review, and sensitivity testing.

Scope of Analysis

Autoimmune Disease Diagnostics Market Breakdown By Product, Technology, And Region

Parameter Details
Quantitative Units USD 6.5 billion to USD 11.9 billion, at a CAGR of 6.3%
Market Definition The Autoimmune Disease Diagnostics Market covers products, technologies, and services across product, technology, disease type categories for commercial, institutional, and consumer applications.
Regions Covered North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered USA, Canada, UK, Germany, China, India, 30 plus countries
Key Companies F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, Abbott, Beckman Coulter, Inc., Danaher Corporation, Quest Diagnostics, EUROIMMUN Medizinische Labordiagnostika AG, Nova Diagnostics Pte Ltd, Biomérieux, Hemagen Diagnostics, Inc.
Forecast Period 2026 to 2036
Approach Hybrid demand-side and top-down methodology built on country-level application demand, product benchmarking, pricing analysis, shipment validation, and primary interviews across manufacturers, distributors, and end users

Autoimmune Disease Diagnostics Market Segmentation

  • Autoimmune Disease Diagnostics Market Segmented by Product:

    • Immunoassay Based Diagnostics
      • Enzyme Linked Immunosorbent Assay
      • Chemiluminescence Immunoassay
      • Radioimmunoassay
    • Molecular Diagnostics
      • Polymerase Chain Reaction Assays
      • Real Time PCR Kits
      • Next Generation Sequencing Panels
    • Autoantibody Tests
      • Antinuclear Antibody Test
      • Anti Double Stranded DNA Test
      • Rheumatoid Factor Test
      • Complement Assays
    • Point of Care Diagnostics
      • Rapid Immunoassay Kits
      • Lateral Flow Assays
    • Multiplex Diagnostic Panels
      • Multiplex Autoimmune Panels
      • Syndromic Testing Panels
    • Specialized Diagnostic Kits
      • Celiac Disease Testing Kits
      • Thyroid Function Autoimmune Panels
      • Type 1 Diabetes Autoantibody Panels

  • Autoimmune Disease Diagnostics Market Segmented by Technology:

    • Immunodiagnostics Technology
      • Enzyme Immunoassay Technology
      • Chemiluminescent Detection Systems
    • Fluorescence Based Technology
      • Flow Cytometry Based Assays
      • Multiplex Fluorescent Detection
    • Molecular Diagnostics Technology
      • PCR Based Detection Systems
      • Genetic Sequencing Platforms
    • Biosensor Technology
      • Electrochemical Biosensors
      • Biochip Based Detection
    • Automated Laboratory Systems
      • High Throughput Analyzer Systems
      • Integrated Lab Automation Platforms

  • Autoimmune Disease Diagnostics Market Segmented by Disease Type:

    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
      • Cutaneous Lupus
      • Systemic Lupus Variants
    • Celiac Disease
      • Gluten Sensitive Enteropathy
      • Advanced Celiac Screening
    • Type 1 Diabetes
      • Adult Onset Type 1 Diabetes
      • Juvenile Type 1 Diabetes
    • Thyroid Autoimmune Disorders
      • Hashimoto Thyroiditis
      • Graves Disease
    • Multiple Sclerosis
      • Relapsing Remitting Multiple Sclerosis
      • Progressive Multiple Sclerosis
    • Inflammatory Bowel Disease
      • Crohn Disease
      • Ulcerative Colitis

  • Autoimmune Disease Diagnostics Market Segmented by Sample Type:

    • Blood Samples
      • Serum Based Testing
      • Plasma Based Testing
    • Saliva Samples
    • Urine Samples
    • Tissue Samples
      • Biopsy Based Diagnostics
      • Immunohistochemistry Samples

  • Autoimmune Disease Diagnostics Market Segmented by End Use:

    • Hospitals
      • Tertiary Care Hospitals
      • Diagnostic Departments
    • Diagnostic Laboratories
      • Independent Clinical Laboratories
      • Hospital Based Laboratories
    • Research Institutes
      • Autoimmune Research Centers
      • Academic Medical Institutions
    • Specialty Clinics
      • Rheumatology Clinics
      • Endocrinology Clinics

  • Autoimmune Disease Diagnostics Market by Region:

    • North America
      • USA
      • Canada
      • Mexico
    • Latin America
      • Brazil
      • Chile
      • Rest of Latin America
    • Western Europe
      • Germany
      • UK
      • Italy
      • Spain
      • France
      • Nordic
      • BENELUX
      • Rest of Western Europe
    • Eastern Europe
      • Russia
      • Poland
      • Hungary
      • Balkan & Baltic
      • Rest of Eastern Europe
    • East Asia
      • China
      • Japan
      • South Korea
    • South Asia and Pacific
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of South Asia and Pacific
    • Middle East & Africa
      • Kingdom of Saudi Arabia
      • Other GCC Countries
      • Turkiye
      • South Africa
      • Other African Union
      • Rest of Middle East & Africa

- Frequently Asked Questions -

How big is the autoimmune disease diagnostics market in 2026?

The global autoimmune disease diagnostics market is estimated to be valued at USD 6.5 billion in 2026.

What will be the size of autoimmune disease diagnostics market in 2036?

The market size for the autoimmune disease diagnostics market is projected to reach USD 11.9 billion by 2036.

How much will be the autoimmune disease diagnostics market growth between 2026 and 2036?

The autoimmune disease diagnostics market is expected to grow at a 6.3% CAGR between 2026 and 2036.

What are the key product types in the autoimmune disease diagnostics market?

The key product types in autoimmune disease diagnostics market are immunoassay based diagnostics, molecular diagnostics, autoantibody tests, point of care diagnostics, multiplex diagnostic panels and specialized diagnostic kits.

Which technology segment is expected to contribute significant share in the autoimmune disease diagnostics market in 2026?

In terms of technology, immunodiagnostics technology segment is expected to command 41.5% share in the autoimmune disease diagnostics market in 2026.

Table of Content

  1. Executive Summary
    • Global Market Outlook
    • Demand to side Trends
    • Supply to side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Research Methodology
    • Chapter Orientation
    • Analytical Lens and Working Hypotheses
      • Market Structure, Signals, and Trend Drivers
      • Benchmarking and Cross-market Comparability
      • Market Sizing, Forecasting, and Opportunity Mapping
    • Research Design and Evidence Framework
      • Desk Research Programme (Secondary Evidence)
        • Company Annual and Sustainability Reports
        • Peer-reviewed Journals and Academic Literature
        • Corporate Websites, Product Literature, and Technical Notes
        • Earnings Decks and Investor Briefings
        • Statutory Filings and Regulatory Disclosures
        • Technical White Papers and Standards Notes
        • Trade Journals, Industry Magazines, and Analyst Briefs
        • Conference Proceedings, Webinars, and Seminar Materials
        • Government Statistics Portals and Public Data Releases
        • Press Releases and Reputable Media Coverage
        • Specialist Newsletters and Curated Briefings
        • Sector Databases and Reference Repositories
        • Fact.MR Internal Proprietary Databases and Historical Market Datasets
        • Subscription Datasets and Paid Sources
        • Social Channels, Communities, and Digital Listening Inputs
        • Additional Desk Sources
      • Expert Input and Fieldwork (Primary Evidence)
        • Primary Modes
          • Qualitative Interviews and Expert Elicitation
          • Quantitative Surveys and Structured Data Capture
          • Blended Approach
        • Why Primary Evidence is Used
        • Field Techniques
          • Interviews
          • Surveys
          • Focus Groups
          • Observational and In-context Research
          • Social and Community Interactions
        • Stakeholder Universe Engaged
          • C-suite Leaders
          • Board Members
          • Presidents and Vice Presidents
          • R&D and Innovation Heads
          • Technical Specialists
          • Domain Subject-matter Experts
          • Scientists
          • Physicians and Other Healthcare Professionals
        • Governance, Ethics, and Data Stewardship
          • Research Ethics
          • Data Integrity and Handling
      • Tooling, Models, and Reference Databases
    • Data Engineering and Model Build
      • Data Acquisition and Ingestion
      • Cleaning, Normalisation, and Verification
      • Synthesis, Triangulation, and Analysis
    • Quality Assurance and Audit Trail
  4. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  5. Global Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
    • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
      • Y to o to Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  6. Global Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
  7. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Product
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Product, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Product, 2026 to 2036
      • Immunoassay Based Diagnostics
        • Enzyme Linked Immunosorbent Assay
        • Chemiluminescence Immunoassay
        • Radioimmunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction Assays
        • Real Time PCR Kits
        • Next Generation Sequencing Panels
      • Autoantibody Tests
        • Antinuclear Antibody Test
        • Anti Double Stranded DNA Test
        • Rheumatoid Factor Test
        • Complement Assays
      • Point of Care Diagnostics
        • Rapid Immunoassay Kits
        • Lateral Flow Assays
      • Multiplex Diagnostic Panels
        • Multiplex Autoimmune Panels
        • Syndromic Testing Panels
      • Specialized Diagnostic Kits
        • Celiac Disease Testing Kits
        • Thyroid Function Autoimmune Panels
        • Type 1 Diabetes Autoantibody Panels
    • Y to o to Y Growth Trend Analysis By Product, 2021 to 2025
    • Absolute $ Opportunity Analysis By Product, 2026 to 2036
  8. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Technology
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Technology, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Technology, 2026 to 2036
      • Immunodiagnostics Technology
        • Enzyme Immunoassay Technology
        • Chemiluminescent Detection Systems
      • Fluorescence Based Technology
        • Flow Cytometry Based Assays
        • Multiplex Fluorescent Detection
      • Molecular Diagnostics Technology
        • PCR Based Detection Systems
        • Genetic Sequencing Platforms
      • Biosensor Technology
        • Electrochemical Biosensors
        • Biochip Based Detection
      • Automated Laboratory Systems
        • High Throughput Analyzer Systems
        • Integrated Lab Automation Platforms
    • Y to o to Y Growth Trend Analysis By Technology, 2021 to 2025
    • Absolute $ Opportunity Analysis By Technology, 2026 to 2036
  9. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Disease Type
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Disease Type, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Disease Type, 2026 to 2036
      • Rheumatoid Arthritis
        • Seropositive Rheumatoid Arthritis
        • Seronegative Rheumatoid Arthritis
      • Systemic Lupus Erythematosus
        • Cutaneous Lupus
        • Systemic Lupus Variants
      • Celiac Disease
        • Gluten Sensitive Enteropathy
        • Advanced Celiac Screening
      • Type 1 Diabetes
        • Adult Onset Type 1 Diabetes
        • Juvenile Type 1 Diabetes
      • Thyroid Autoimmune Disorders
        • Hashimoto Thyroiditis
        • Graves Disease
      • Multiple Sclerosis
        • Relapsing Remitting Multiple Sclerosis
        • Progressive Multiple Sclerosis
      • Inflammatory Bowel Disease
        • Crohn Disease
        • Ulcerative Colitis
    • Y to o to Y Growth Trend Analysis By Disease Type, 2021 to 2025
    • Absolute $ Opportunity Analysis By Disease Type, 2026 to 2036
  10. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Sample Type
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Sample Type, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Sample Type, 2026 to 2036
      • Blood Samples
        • Serum Based Testing
        • Plasma Based Testing
      • Saliva Samples
      • Urine Samples
      • Tissue Samples
        • Biopsy Based Diagnostics
        • Immunohistochemistry Samples
    • Y to o to Y Growth Trend Analysis By Sample Type, 2021 to 2025
    • Absolute $ Opportunity Analysis By Sample Type, 2026 to 2036
  11. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By End Use
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By End Use, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By End Use, 2026 to 2036
      • Hospitals
        • Tertiary Care Hospitals
        • Diagnostic Departments
      • Diagnostic Laboratories
        • Independent Clinical Laboratories
        • Hospital Based Laboratories
      • Research Institutes
        • Autoimmune Research Centers
        • Academic Medical Institutions
      • Specialty Clinics
        • Rheumatology Clinics
        • Endocrinology Clinics
    • Y to o to Y Growth Trend Analysis By End Use, 2021 to 2025
    • Absolute $ Opportunity Analysis By End Use, 2026 to 2036
  12. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
      • North America
      • Latin America
      • Western Europe
      • Eastern Europe
      • East Asia
      • South Asia and Pacific
      • Middle East & Africa
    • Market Attractiveness Analysis By Region
  13. North America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • USA
        • Canada
        • Mexico
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Key Takeaways
  14. Latin America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Brazil
        • Chile
        • Rest of Latin America
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Key Takeaways
  15. Western Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Germany
        • UK
        • Italy
        • Spain
        • France
        • Nordic
        • BENELUX
        • Rest of Western Europe
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Key Takeaways
  16. Eastern Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Russia
        • Poland
        • Hungary
        • Balkan & Baltic
        • Rest of Eastern Europe
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Key Takeaways
  17. East Asia Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • China
        • Japan
        • South Korea
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Key Takeaways
  18. South Asia and Pacific Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of South Asia and Pacific
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Key Takeaways
  19. Middle East & Africa Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Kingdom of Saudi Arabia
        • Other GCC Countries
        • Turkiye
        • South Africa
        • Other African Union
        • Rest of Middle East & Africa
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
    • Key Takeaways
  20. Key Countries Market Analysis
    • USA
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Canada
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Mexico
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Brazil
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Chile
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • UK
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Italy
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Spain
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • France
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • India
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • ASEAN
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Australia & New Zealand
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • China
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Japan
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • South Korea
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Russia
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Poland
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Hungary
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Kingdom of Saudi Arabia
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • Turkiye
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
    • South Africa
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Product
        • By Technology
        • By Disease Type
        • By Sample Type
        • By End Use
  21. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Product
      • By Technology
      • By Disease Type
      • By Sample Type
      • By End Use
  22. Competition Analysis
    • Competition Deep Dive
      • F. Hoffmann-La Roche Ltd
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • Siemens Healthcare Private Limited
      • Abbott
      • Beckman Coulter, Inc.
      • Danaher Corporation
      • Quest Diagnostics
      • EUROIMMUN Medizinische Labordiagnostika AG
      • Nova Diagnostics Pte Ltd
      • Biomérieux
      • Hemagen Diagnostics, Inc.
  23. Assumptions & Acronyms Used

List Of Table

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
  • Table 2: Global Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 3: Global Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 4: Global Market Value (USD Million) Forecast by Disease Type, 2021 to 2036
  • Table 5: Global Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 6: Global Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 7: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 8: North America Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 9: North America Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 10: North America Market Value (USD Million) Forecast by Disease Type, 2021 to 2036
  • Table 11: North America Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 12: North America Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 13: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 14: Latin America Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 15: Latin America Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 16: Latin America Market Value (USD Million) Forecast by Disease Type, 2021 to 2036
  • Table 17: Latin America Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 18: Latin America Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 19: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 20: Western Europe Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 21: Western Europe Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 22: Western Europe Market Value (USD Million) Forecast by Disease Type, 2021 to 2036
  • Table 23: Western Europe Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 24: Western Europe Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 25: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 26: Eastern Europe Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 27: Eastern Europe Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 28: Eastern Europe Market Value (USD Million) Forecast by Disease Type, 2021 to 2036
  • Table 29: Eastern Europe Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 30: Eastern Europe Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 31: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 32: East Asia Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 33: East Asia Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 34: East Asia Market Value (USD Million) Forecast by Disease Type, 2021 to 2036
  • Table 35: East Asia Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 36: East Asia Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 37: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 38: South Asia and Pacific Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 39: South Asia and Pacific Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 40: South Asia and Pacific Market Value (USD Million) Forecast by Disease Type, 2021 to 2036
  • Table 41: South Asia and Pacific Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 42: South Asia and Pacific Market Value (USD Million) Forecast by End Use, 2021 to 2036
  • Table 43: Middle East & Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 44: Middle East & Africa Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 45: Middle East & Africa Market Value (USD Million) Forecast by Technology, 2021 to 2036
  • Table 46: Middle East & Africa Market Value (USD Million) Forecast by Disease Type, 2021 to 2036
  • Table 47: Middle East & Africa Market Value (USD Million) Forecast by Sample Type, 2021 to 2036
  • Table 48: Middle East & Africa Market Value (USD Million) Forecast by End Use, 2021 to 2036

List Of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2021 to 2036
  • Figure 3: Global Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 4: Global Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 5: Global Market Attractiveness Analysis by Product
  • Figure 6: Global Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 7: Global Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 8: Global Market Attractiveness Analysis by Technology
  • Figure 9: Global Market Value Share and BPS Analysis by Disease Type, 2026 and 2036
  • Figure 10: Global Market Y-o-Y Growth Comparison by Disease Type, 2026 to 2036
  • Figure 11: Global Market Attractiveness Analysis by Disease Type
  • Figure 12: Global Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 13: Global Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 14: Global Market Attractiveness Analysis by Sample Type
  • Figure 15: Global Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 16: Global Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 17: Global Market Attractiveness Analysis by End Use
  • Figure 18: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
  • Figure 19: Global Market Y-o-Y Growth Comparison by Region, 2026 to 2036
  • Figure 20: Global Market Attractiveness Analysis by Region
  • Figure 21: North America Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 22: Latin America Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 23: Western Europe Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 24: Eastern Europe Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 25: East Asia Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 26: South Asia and Pacific Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 27: Middle East & Africa Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 28: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 29: North America Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 30: North America Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 31: North America Market Attractiveness Analysis by Product
  • Figure 32: North America Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 33: North America Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 34: North America Market Attractiveness Analysis by Technology
  • Figure 35: North America Market Value Share and BPS Analysis by Disease Type, 2026 and 2036
  • Figure 36: North America Market Y-o-Y Growth Comparison by Disease Type, 2026 to 2036
  • Figure 37: North America Market Attractiveness Analysis by Disease Type
  • Figure 38: North America Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 39: North America Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 40: North America Market Attractiveness Analysis by Sample Type
  • Figure 41: North America Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 42: North America Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 43: North America Market Attractiveness Analysis by End Use
  • Figure 44: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 45: Latin America Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 46: Latin America Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 47: Latin America Market Attractiveness Analysis by Product
  • Figure 48: Latin America Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 49: Latin America Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 50: Latin America Market Attractiveness Analysis by Technology
  • Figure 51: Latin America Market Value Share and BPS Analysis by Disease Type, 2026 and 2036
  • Figure 52: Latin America Market Y-o-Y Growth Comparison by Disease Type, 2026 to 2036
  • Figure 53: Latin America Market Attractiveness Analysis by Disease Type
  • Figure 54: Latin America Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 55: Latin America Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 56: Latin America Market Attractiveness Analysis by Sample Type
  • Figure 57: Latin America Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 58: Latin America Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 59: Latin America Market Attractiveness Analysis by End Use
  • Figure 60: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 61: Western Europe Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 62: Western Europe Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 63: Western Europe Market Attractiveness Analysis by Product
  • Figure 64: Western Europe Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 65: Western Europe Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 66: Western Europe Market Attractiveness Analysis by Technology
  • Figure 67: Western Europe Market Value Share and BPS Analysis by Disease Type, 2026 and 2036
  • Figure 68: Western Europe Market Y-o-Y Growth Comparison by Disease Type, 2026 to 2036
  • Figure 69: Western Europe Market Attractiveness Analysis by Disease Type
  • Figure 70: Western Europe Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 71: Western Europe Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 72: Western Europe Market Attractiveness Analysis by Sample Type
  • Figure 73: Western Europe Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 74: Western Europe Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 75: Western Europe Market Attractiveness Analysis by End Use
  • Figure 76: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 77: Eastern Europe Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 78: Eastern Europe Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 79: Eastern Europe Market Attractiveness Analysis by Product
  • Figure 80: Eastern Europe Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 81: Eastern Europe Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 82: Eastern Europe Market Attractiveness Analysis by Technology
  • Figure 83: Eastern Europe Market Value Share and BPS Analysis by Disease Type, 2026 and 2036
  • Figure 84: Eastern Europe Market Y-o-Y Growth Comparison by Disease Type, 2026 to 2036
  • Figure 85: Eastern Europe Market Attractiveness Analysis by Disease Type
  • Figure 86: Eastern Europe Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 87: Eastern Europe Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 88: Eastern Europe Market Attractiveness Analysis by Sample Type
  • Figure 89: Eastern Europe Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 90: Eastern Europe Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 91: Eastern Europe Market Attractiveness Analysis by End Use
  • Figure 92: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 93: East Asia Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 94: East Asia Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 95: East Asia Market Attractiveness Analysis by Product
  • Figure 96: East Asia Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 97: East Asia Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 98: East Asia Market Attractiveness Analysis by Technology
  • Figure 99: East Asia Market Value Share and BPS Analysis by Disease Type, 2026 and 2036
  • Figure 100: East Asia Market Y-o-Y Growth Comparison by Disease Type, 2026 to 2036
  • Figure 101: East Asia Market Attractiveness Analysis by Disease Type
  • Figure 102: East Asia Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 103: East Asia Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 104: East Asia Market Attractiveness Analysis by Sample Type
  • Figure 105: East Asia Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 106: East Asia Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 107: East Asia Market Attractiveness Analysis by End Use
  • Figure 108: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 109: South Asia and Pacific Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 110: South Asia and Pacific Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 111: South Asia and Pacific Market Attractiveness Analysis by Product
  • Figure 112: South Asia and Pacific Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 113: South Asia and Pacific Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 114: South Asia and Pacific Market Attractiveness Analysis by Technology
  • Figure 115: South Asia and Pacific Market Value Share and BPS Analysis by Disease Type, 2026 and 2036
  • Figure 116: South Asia and Pacific Market Y-o-Y Growth Comparison by Disease Type, 2026 to 2036
  • Figure 117: South Asia and Pacific Market Attractiveness Analysis by Disease Type
  • Figure 118: South Asia and Pacific Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 119: South Asia and Pacific Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 120: South Asia and Pacific Market Attractiveness Analysis by Sample Type
  • Figure 121: South Asia and Pacific Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 122: South Asia and Pacific Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 123: South Asia and Pacific Market Attractiveness Analysis by End Use
  • Figure 124: Middle East & Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 125: Middle East & Africa Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 126: Middle East & Africa Market Y-o-Y Growth Comparison by Product, 2026 to 2036
  • Figure 127: Middle East & Africa Market Attractiveness Analysis by Product
  • Figure 128: Middle East & Africa Market Value Share and BPS Analysis by Technology, 2026 and 2036
  • Figure 129: Middle East & Africa Market Y-o-Y Growth Comparison by Technology, 2026 to 2036
  • Figure 130: Middle East & Africa Market Attractiveness Analysis by Technology
  • Figure 131: Middle East & Africa Market Value Share and BPS Analysis by Disease Type, 2026 and 2036
  • Figure 132: Middle East & Africa Market Y-o-Y Growth Comparison by Disease Type, 2026 to 2036
  • Figure 133: Middle East & Africa Market Attractiveness Analysis by Disease Type
  • Figure 134: Middle East & Africa Market Value Share and BPS Analysis by Sample Type, 2026 and 2036
  • Figure 135: Middle East & Africa Market Y-o-Y Growth Comparison by Sample Type, 2026 to 2036
  • Figure 136: Middle East & Africa Market Attractiveness Analysis by Sample Type
  • Figure 137: Middle East & Africa Market Value Share and BPS Analysis by End Use, 2026 and 2036
  • Figure 138: Middle East & Africa Market Y-o-Y Growth Comparison by End Use, 2026 to 2036
  • Figure 139: Middle East & Africa Market Attractiveness Analysis by End Use
  • Figure 140: Global Market - Tier Structure Analysis
  • Figure 141: Global Market - Company Share Analysis
Related Reports

Related Reports

Autoimmune Disease Diagnostics Market

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services